Filter

791 - 800 of 828 Results

  • Report Of Technical Advisory Group On Lovelife South Africa Site Visit

    Report

    In January 2002, an international Technical Advisory Group (TAG) traveled to South Africa to observe the programs and to make recommendations on strengthening loveLife's overall strategy. The TAG strongly and unanimously felt the loveLife project should be both continued and expanded.

  • PSAs in a New Media Age Background Papers

    Report

    A new national study on public service advertising finds that broadcast and cable television networks donate an average of 15 seconds an hour to air public service ads (PSAs), representing just under one-half of one percent (0.4%) of all airtime.

  • PSAs in a New Media Age Case Studies

    Other Post

    A new national study on public service advertising finds that broadcast and cable television networks donate an average of 15 seconds an hour to air public service ads (PSAs), representing just under one-half of one percent (0.4%) of all airtime.

  • PSAs in a New Media Age Executive Summary

    Report

    A new national study on public service advertising finds that broadcast and cable television networks donate an average of 15 seconds an hour to air public service ads (PSAs), representing just under one-half of one percent (0.4%) of all airtime.

  • PSAs in a New Media Age Report: TV Content

    Report

    PSAs in a New Media Age A new national study on public service advertising finds that broadcast and cable television networks donate an average of 15 seconds an hour to air public service ads (PSAs), representing just under one-half of one percent (0.4%) of all airtime.

  • Looking at loveLife: The First Year

    Other Post

    Looking at loveLife: The First YearSummaries of Monitoring and Evaluation loveLife is a deliberate departure from traditional approaches to HIV prevention, relying on a combination of commercial marketing and public health techniques to promote a new healthy lifestyle among a 12-17 year old target group - identified at highest risk of HIV infection.

  • Clinical Drug Trials Helpful or Harmful? Dilemma of Using Drugs to Prevent Diseases in People Who are at Risk but Otherwise Healthy, Especially When the Drugs Have Serious Side Effects

    Other Post

    Host: Nick Adams; Reporter: Joe Palca Reprinted with permission of National Public Radio NOAH ADAMS, host: Any doctor will tell you that preventing a disease is better than treating one. But disease prevention can be tricky. Virtually anything you do to lower the risk for one disease raises the risk of something else.